Article Authors: Linda Morrow, Douglas B Muchmore, Elizabeth A Ludington, Daniel E Vaughn, Marcus Hompesch
Abstract
This study was designed to test the hypothesis that co-administration of recombinant human hyaluronidase (rHuPH20) with regular insulin or insulin lispro will reduce intrasubject variability in pharmacokinetic end points compared with lispro alone.